Metabolic research / Product 07

Tirzepatide

10mg vial

$169USD

Demo product · no payment or shipment will be created

For laboratory research only. This product is not intended for human consumption, medical treatment, veterinary use, or household use.

Product / 07Lyophilized vial

SS—007

10mgMetabolic research

Research use only · Demo product listing

About this product

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Research compares its effects on glucose regulation and weight-related outcomes with single-agonist GLP-1 compounds.

Research topics

Weight and body-composition measures
Combined GIP and GLP-1 receptor activity
Insulin-sensitivity markers
Appetite, energy expenditure, and fat-mass models

What the literature covers

Tirzepatide is widely studied as a multi-agonist with a different mechanism from semaglutide. Research continues to compare the two approaches across metabolic outcomes.

About study methods

Clinical and laboratory studies use different schedules, concentrations, and handling procedures. The primary source should define the setup for any specific experiment.

These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.